Solvonis Therapeutics CEO says dual US patent win strengthens PTSD pipeline
Solvonis Therapeutics CEO says dual US patent win strengthens PTSD pipeline
1 month ago
centralcharts.com
Structure Therapeutics CEO on the company's oral GLP-1 opportunity
4:04
Structure Therapeutics CEO on the company's oral GLP-1 opportunity
1 month ago
CNBC
Cynata Therapeutics (ASX:CYP): ASX Gems | Cynata Therapeutics
Cynata Therapeutics (ASX:CYP): ASX Gems | Cynata Therapeutics
4.5K views4 months ago
linkedin.com
Zevra Therapeutics, Inc. Announces Change of CEO, Effective June 1, 2023
Zevra Therapeutics, Inc. Announces Change of CEO, Effective June 1, 2023
May 8, 2023
marketscreener.com
Horizon Therapeutics CEO on its record 2020 results
2:22
Horizon Therapeutics CEO on its record 2020 results
Feb 24, 2021
CNBC
Agilent CEO Padraig McDonnell sees 'long runway' in advancing therapeutics
3:30
Agilent CEO Padraig McDonnell sees 'long runway' in advancing therapeutics
Dec 17, 2024
MSNCNBC
Solvonis Therapeutics CEO on name change, Awakn acquisition and 2025 priorities
Solvonis Therapeutics CEO on name change, Awakn acquisition and 2025 priorities
Jan 14, 2025
proactiveinvestors.co.uk
0:12
Dr. Shalabh Gupta, Founder, Chairman & CEO of Unicycive Therapeutics, took the stage at the 2025 Healthcare Summit to discuss the crucial pitfalls and opportunities shaping the medical landscape. Presented by Unicycive Learn More: https://bit.ly/4p9AEya | Forbes
673 views4 months ago
FacebookForbes
4:23
Maze Therapeutics CEO Jason Coloma on how the new biotech is taking on Kidney disease
6 months ago
MSNCNBC
2:46
Juno Therapeutics CEO on FDA greenlight
Jul 12, 2016
CNBCMelissa Lee
2:36
Joshua Brumm, CEO of Dyne Therapeutics shares with Nasdaq what’s in store for $DYN for 2023 as they continue to work to advance life-transforming therapies for serious muscle diseases as a member of the Nasdaq Biotech Index. #NationalBiotechnologyMonth #NasdaqListed #JPMHC23 | Nasdaq
522 viewsJan 10, 2023
FacebookNasdaq
6:30
Spark Therapeutics CEO on breakthroughs in gene therapy
Dec 3, 2018
CNBC
2:49
Amicus Therapeutics CEO: Trump constructive for our industry
Mar 1, 2017
CNBC
3:27
Cerevel Therapeutics CEO on going public through a SPAC
Jul 31, 2020
CNBC
7:58
$
TG Therapeutics CEO talks journey to becoming a commercial pharmaceutical company
Jan 14, 2021
CNBC
2:19
Sage Therapeutics CEO: Mental health is integral to returning to work
Sep 10, 2020
CNBC
Prescient Therapeutics CEO on PTX-100: fast track & Phase 2 begins
10 months ago
proactiveinvestors.com.au
7:56
Karuna Therapeutics CEO discusses the biotech firm's drug trials for schizophrenia
Dec 2, 2021
CNBC
3:53
Sage Therapeutics CEO on why its moving to treat depression next
Jul 24, 2019
CNBC
4:07
Watch CNBC's interview with Aimmune Therapeutics CEO on the company's peanut therapy
Sep 16, 2019
CNBCMeg Tirrell
7:47
$
Definium Therapeutics CEO Robert Barrow goes one-on-one with Jim Cramer
3 weeks ago
CNBCJim Cramer
7:42
Sorrento Therapeutics CEO: Start of human trials for our coronavirus drug are 'two to three months away'
Jun 9, 2020
CNBC
6:01
Bright Path CEO explains the importance of producing pharmaceutical drugs in the U.S.
106K viewsDec 6, 2021
YahooYahoo Finance Video
4:24
Structure CEO on the competitive landscape for oral GLP-1 drugs
Dec 5, 2024
MSNCNBC
3:49
Sage CEO on post-partum depression, innovation for the company
Mar 28, 2018
CNBCTyler Mathisen
6:25
Acorda CEO strikes back to Kyle Bass
Sep 16, 2015
CNBCMeg Tirrell
6:42
Sangamo Therapeutics CEO on partnering with Biogen to develop gene-regulation therapies for Alzheimer's and Parkinson's
Mar 6, 2020
CNBC
1:56
Karuna CEO says he doesn't expect company's KarXT schizophrenia drug to lose its efficacy over time
Aug 17, 2022
CNBC
4:54
All leaders have to speak to things that are right and wrong: Former Onyx Pharma CEO
Aug 16, 2017
CNBC
4:19
We're strengthening our work in oncology, which is big for future growth, says Bristol Myers chairman and CEO
Jun 3, 2022
CNBC
See more